Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli

D. A. Strandberg, J. H. Jorgensen, D. J. Drutz

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

The susceptibilities of 159 clinical isolates of glucose nonfermentative gram-negative bacilli were determined for eight new monobactam or β-lactam antibiotics. Imipemide (N-formimidoyl thienamcyin) was effective against the largest number of species, although not against Pseudomonas maltophilia. Cefoperazone and ceftazidime, but not cefsulodin, were active against infrequently isolated Pseudomonas species. Aztreonam, moxalactam, cefotaxime, and ceftizoxime demonstrated selective activity against several species, including certain aminoglycoside-resistant isolates.

Original languageEnglish (US)
Pages (from-to)282-286
Number of pages5
JournalAntimicrobial agents and chemotherapy
Volume24
Issue number2
DOIs
StatePublished - 1983

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli'. Together they form a unique fingerprint.

Cite this